Sort   by:  
 Page size 
UnknownDesign and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections.
Not available
S-EPMC6356596 | biostudies-literature
UnknownBacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus.
Not available
S-EPMC7318012 | biostudies-literature
TranscriptomicsGenome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA
To determine the global effects of ASCT2 inhibition, we used next generation sequencing to determine mRNA expression changes in PC-3 cells treated with BenSer or GPNA for 48 h. Examination of two different ASCT2 inhibitors BenSer and GPNA in prostate cancer cell line PC-3.
ORGANISM(S): Homo sapiens 
2015-04-10 | E-GEOD-65112 | biostudies-arrayexpress
UnknownRelease of transcriptional repression through the HCR promoter region confers uniform expression of HWP1 on surfaces of Candida albicans germ tubes.
Not available
S-EPMC5810986 | biostudies-literature
UnknownTroponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
Not available
S-EPMC7954292 | biostudies-literature
UnknownHumans rather than climate the primary cause of Pleistocene megafaunal extinction in Australia.
Not available
S-EPMC5263868 | biostudies-literature
UnknownTargeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
Not available
S-EPMC4973854 | biostudies-literature
UnknownTropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells.
Not available
S-EPMC3118631 | biostudies-literature
UnknownContrasting the potential benefits of early invasive coronary angiography in acute and chronic myocardial injury patterns.
Not available
S-EPMC10270641 | biostudies-literature
UnknownPlatinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.
Not available
S-EPMC12258326 | biostudies-literature
Sort   by:  
 Page size